Melatonin as premedication for laparoscopic cholecystectomy: A double-blind, placebo-controlled study

Southern African Journal of Anaesthesia and Analgesia

Volumn 14, Issue 4, 2008, Pages 8-11

  Ionescu, D ^a   Badescu C ^b   Itie, C ^b   Miclutia, I ^a   Iancu, C ^a   Ion, D ^c   Vasian, H ^a   Acalovschi, I ^a   Mocan, T ^a   Boncor, C ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Spitalul Clinic de Adulct   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MELATONIN; MIDAZOLAM MALEATE; OPIATE; PLACEBO;

ADULT; AGED; AMNESIA; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANXIETY; ARTICLE; CHOLECYSTECTOMY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; GENERAL ANESTHESIA; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREMEDICATION; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; SEDATION;

EID: 77953462047     PISSN: 22201181     EISSN: None     Source Type: Journal    
DOI: 10.1080/22201173.2008.10872555     Document Type: Article

References (16)

1. Boutin JA, Audipot U, Ferry G, Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005;26:412ñ9.
2. Hattori A, Mighitaka H, ligo M, et al. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int 1995;35:627ñ34.
3. Larson J, Jessen RE, Uz T, et al. Impaired hippocampal long-term potentiaton in melatonin MT2 receptors-deficient mice. Neurosci Lett 2006;393:23ñ6.
4. Uz T, Arstan AD, Kurtuncu M, et al. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res 2005;136:45ñ53.
5. Lissoni P, Barni S, Crispino, S, Tancini G, Frascini F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol 1989;25:784ñ95.
6. Lee YA, Hyun KJ, Tokura H. The effects of skin pressure by clothing on circadian rhythms of core temperature and salivary melatonin. Choronobiol Int 2000;17:783ñ93.
7. Pierpaoli W, Maestroni GJ. Melatonin: a principal neuro-immunoregulatory and anti-stress hormone: its anti-aging effects. J Immunol Lett 1987;16:355ñ61.
8. Wurtman RJ, Zhidanova I. Improvement of sleep quality by melatonin. Lancet 1995;346:1491.
9. Naguib M, Samarkandi AH. Premedication with melatonin: a double blind, placebo-controlled comparison with midazolam. Br J Anaesth 1999;82:875ñ80.
10. Acil M, Basgul E, Celiker V, Karagoz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol 2004;21:553ñ7.
11. Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication in adult patients: a double-blinded, placebo-controlled study. Anesth Analg 2000; 91:473ñ9.
12. Naguib M, Hammond DL, Schmidt PG, et al. Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol. Br J Anaesth 2003;90:504ñ7.
13. Lewis KS, McCarthy RJ, Rothenberg DM. Does melatonin decrease sedative use and time to extubation in patients requiring prolonged mechanical ventilation? Anesth Analg 1999;88;S1ñ423.
14. Spielberger CD, Gorsuch RL, Lushene RD. Manual for the state-trait anxiety inventory. Palo Alto CA: Consulting Psychologist Press; 1970.
15. Spilberger CD, Sarason IG. Stress and anxiety. Washington DC: Hemisphere; 1978.
16. Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak, S, Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of β-endorphin an endogenous opioid. Brain Res Bull 2005,64(6):471-479.